Every two seconds, someone in the world needs blood—but far too few people step forward to donate. Whether it’s for accident victims, cancer patients, or those undergoing major surgeries, the demand for safe, healthy blood is constant and often urgent. Yet many potential donors hesitate, held back by fear, misinformation, or uncertainty. On World Blood Donor Day and beyond, it’s time to break down those doubts, understand the life-saving impact of one donation, and discover how giving blood could be easier—and more rewarding—than you think.
While blood donation is widely regarded as an act of altruism, what often goes unnoticed is the remarkable impact it has—not just on the recipients, but also on the donors themselves. Despite major awareness campaigns, myths and fears still prevent a significant portion of eligible individuals from rolling up their sleeves.
Every single blood donation has the potential to save up to three lives. According to Dr. Lopita Bhattacharya, a medical officer blood bank at BM Birla Heart Hospital, “One pint of donated blood is separated into red cells, plasma, and platelets, each of which can be administered to patients based on individual needs—be it trauma victims, cancer patients, surgical patients, or those with chronic blood disorders.”
At any NABH-accredited blood bank, no part of donated blood goes to waste. “Safety, accuracy, and quality are given utmost priority. The entire process is handled with the latest technology and rigorous screening,” she adds.
Dr. Umakant Mokalikar, Blood Centre Incharge at Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune echoes the sentiment. “There is no substitute for human blood. Every donor plays a vital role in the healthcare system, especially in emergencies. Blood donation is truly a humanitarian act.”
Despite awareness, misinformation continues to hinder blood donation drives. Experts say that correcting these myths is the first step to building a more robust and reliable donor base.
Fact: “The fluid components are replaced within 24 hours, and red blood cells regenerate within weeks,” says Dr. Bhattacharya. Healthy men can safely donate every 3 months; women, every 4 months.
Fact: “The blood draw itself only takes 8–10 minutes. Including the screening and post-donation rest, the entire visit wraps up in under 45 minutes,” Dr. Bhattacharya clarifies.
Fact: Common blood types are often in higher demand due to their compatibility across patient populations. “Every blood type is essential—be it for surgeries, maternity care, or injuries,” she notes.
Fact: If you're between 18–65 years, in good health, and meet minimum weight and hemoglobin thresholds, you’re eligible. First-time donors can donate until age 60.
Fact: “Aside from temporary conditions like menstruation or lactation, women can and should donate blood if they meet eligibility,” Dr. Mokalikar emphasizes.
Fact: The process uses sterile, one-time-use equipment. “There’s zero risk of catching infections,” he reassures.
Donating blood is not just a selfless gesture; it comes with tangible health perks.
Improved heart health: “Regular donation helps lower iron overload in the body, which is linked to reduced risk of cardiovascular diseases,” Dr. Bhattacharya shares.
Calorie burn: One blood donation session can burn around 600–650 calories, similar to a light workout.
Stimulates red blood cell production: “Donation encourages bone marrow to generate fresh red cells, helping keep your circulatory system active,” she explains.
A mini health screening: Donors undergo blood pressure, hemoglobin, and pulse checks. Blood is also screened for infections like HIV, Hepatitis B & C, providing an early warning system for the donor’s own health.
Mental well-being: “The psychological benefit—knowing you’ve potentially saved lives—releases endorphins and improves mood,” adds Dr. Mokalikar.
Once donated, your blood is processed into three core components:
Packed Red Blood Cells (PRBCs): Used in trauma, surgeries, and patients with anemia or cancer.
Platelet Concentrates: Vital for patients with clotting disorders, infections, or undergoing chemotherapy.
Fresh Frozen Plasma (FFP): Used in patients with liver failure or bleeding disorders.
This separation maximizes the utility of a single donation—reaching three different patients with three different medical needs.
According to WHO, less than 1% of the eligible population donates blood in many countries—a number that needs urgent improvement. “If more people come forward regularly, hospitals will have the reserves to act swiftly during crises like accidents, natural disasters, or major surgeries,” urges Dr. Mokalikar.
He adds, “Blood donation is not a one-time favor. Men can donate every 3 months, and women every 4 months. Routine donations help keep blood stocks consistent and reliable.”
Blood donation is one of the most powerful acts of human kindness, and one of the simplest. The entire process—from screening to actual donation and rest—takes less than an hour but leaves a lasting impact. As Dr. Bhattacharya puts it, “It’s free, it’s safe, and it helps others while improving your own health. Why wait?”
Credits: Canva
It’s easy to assume that serious health risks are a concern for later in life. For most young men in their 20s and 30s, long-term health is something they discuss in relation to staying fit, maintaining a balance between job and life, and remaining active. But behind the scenes, there's a silent danger brewing that doesn't carry vehement warning signs or agonizing symptoms, yet is increasing amongst this demographic. And shockingly, nearly 90% of young men don't even know they might be impacted. The truth is, being attuned to your body now might save your life down the road. Here's why medical professionals are urging young men to listen up.
Roughly 10,000 new instances of testicular cancer are diagnosed annually in the United States, according to the American Cancer Society, with an average age of diagnosis of only 33. Unlike the majority of the other cancers that occur later in life, this cancer comes early—most commonly between 20 and 40 years of age.
However, only 13% of the American adults polled recognized that testicular cancer is more frequent among young men and thus ranks as one of the most underappreciated dangers in young adult male health.
Testicular cancer is not only uncommon; it's not well understood. "From my experience, many men are surprised testicular cancer is most prevalent among young men," adds Dr. Shawn Dason, an Ohio State urologist and lead author of the study. "You're just not expecting it in your thirties or twenties."
In contrast to certain types of cancer with sets of initial warning signs, testicular cancer tends to be painless and thus more difficult to notice through sheer habit. The consequence? Late-stage diagnoses that lower survival rates.
Though survival after five years is 95% if caught early, this drops to 73% if the condition becomes widespread beyond the testicle. Despite the high cure rate, however, just 35% of survey respondents thought screening under age 40 is required.
Adding to the threat is that the symptoms—if any—are insidious:
Far too frequently, these symptoms are overlooked, dismissed, or go unnoticed because of the lack of overall awareness.
The reason why testicular cancer so heavily strikes younger men is still being researched, but it is thought to be attributed to germ cell activity, which is greater at a man's reproductive prime. These germ cells, used to make sperm, can become mutated and give rise to tumors.
Some of the risk factors are:
And, for some reason, being overweight hasn't proved to be a major risk factor—despite its link with so many other cancers.
A 2024 study from California found testicular cancer rates in men under 39 increased by 10% over two decades, climbing from 6 to 7.3 cases per 100,000 people. According to the CDC, national figures mirrored the trend, with an increase from 6.3 to 6.8 cases per 100,000 men aged 0–39 between 1999 and 2021.
Experts credit this increase to enhanced screening and environmental or lifestyle factors possibly impacting the development of germ cell tumors in young men.
Early detection is a good thing—and it starts at home. The Testicular Cancer Foundation advises a monthly self-exam, preferably after a warm shower when scrotal skin is soft.
STEP 1- Visually check for swelling, asymmetry, or change.
STEP 2- Gently explore each testicle with thumb and fingers.
STEP 3- Check for lumps, hard spots, or rapid change in size, weight, or texture.
STEP 4- Check for pain, heaviness, or tenderness.
If you find anything abnormal, consult a doctor at once—ideally a urologist. You might be sent for an ultrasound or blood test.
Even with this easy and possibly life-saving measure, only 54% of men were aware they need to perform monthly self-exams, according to the Ohio State study—and the number that actually do so is probably much less.
The majority of testicular cancers are treated successfully, particularly if diagnosed early. The initial course of treatment is surgery, where the cancerous testicle is surgically removed. This surgery, an orchiectomy, is usually followed by:
Most men continue to have healthy, active lives after treatment, such as professional athletes Nathan Adrian, an Olympic swimmer, and cyclist Lance Armstrong. Both were diagnosed in their 20s and underwent successful treatment following early detection.
The larger concern is not testicular cancer—but men's overall attitude towards their health. Men under age 40 typically avoid preventive care, letting career pressure and everyday life interfere.
Dr. Dason places a premium on mindset change: "We need to make health check-ups and being aware of one's body 'normal' among men in their 20s and 30s. Waiting for symptoms is waiting too long."
Awareness is your most powerful ally in the fight against testicular cancer. If you’re a young man—or know one—start talking about this. Normalize self-exams, reduce stigma, and encourage open conversations with healthcare providers because when caught early, testicular cancer is not just treatable—it’s beatable.
Credits: Canva
Cervical cancer, though almost entirely preventable, continues to claim over 350,000 lives each year — most of them women in developing countries. India carries one of the heaviest burdens. But it doesn’t have to be this way. Science has handed us the tools — vaccines, DNA-based screening, and effective treatments. The real hurdle? Making sure these solutions reach everyone, regardless of gender, geography, or income.
At the heart of the cervical cancer crisis is the Human Papillomavirus (HPV), one of the most common sexually transmitted infections worldwide. Most HPV infections resolve on their own. But when certain high-risk genotypes persist, they can lead to various cancers — not just cervical, but also anal, penile, vulvar, vaginal, and oropharyngeal.
According to the World Health Organization (WHO), virtually all cervical cancer cases are caused by HPV. Every eight minutes, a woman in India dies of this disease — a stark statistic for something that could be prevented with timely vaccination and screening.
While cervical cancer has gained some attention, HPV-related cancers in men remain dangerously underdiagnosed. In 2019 alone, over 70,000 cancer cases in men were caused by HPV — a number many experts say is underestimated.
This was underscored by a recent study presented at the 10th Asia Pacific AIDS and Co-Infections Conference in Japan. Conducted by Dr Prapti Gilada-Toshinwal at a Mumbai clinic, it screened 105 men who have sex with men. The findings were worrying — 62% had anal HPV infections, rising to nearly 69% among those living with HIV. Many were also battling other sexually transmitted infections, pointing to an urgent need for integrated sexual health services.
Globally, experts agree that the best way to detect HPV is through DNA-based molecular tests. Traditional screening methods like Pap smears or VIA (Visual Inspection with Acetic Acid) are no longer considered scientifically adequate.
Yet, India’s most recent National Family Health Survey revealed that only 1.2% of women aged 15–49 had ever been screened for cervical cancer. WHO recommends that 70% of eligible women should be screened — a target India is far from achieving.
In a promising development, April 2025 saw the validation of Truenat HPV-HR Plus, India’s first indigenous point-of-care HPV DNA test. Developed by Molbio Diagnostics and approved by leading institutions like AIIMS Delhi and ICMR’s research bodies, Truenat can detect eight high-risk HPV genotypes responsible for most cervical cancers. It’s fast, affordable, and adaptable for rural clinics — exactly the kind of innovation needed to scale up screening access.
Vaccination remains our most powerful tool. A WHO-IARC study, led in part by Indian researcher Dr Smita Joshi, revealed that even one dose of the HPV vaccine offers strong protection. This has led to WHO recommending a single-dose vaccine schedule for young girls.
India’s own vaccine, Ceravac, developed by the Serum Institute, is approved for boys as well. Yet, a national rollout remains pending, even as a few states like Delhi and Punjab have begun pilot programs.
Activists like Vijay Nair of Udaan Trust stress the need to include men in both vaccination and screening programs. Anal cancers are often missed or misdiagnosed in men, especially those from marginalized communities. Without proper diagnostic facilities like anoscopy centres and broader awareness, many are left untreated — or worse, undiagnosed.
The WHO has set ambitious targets to eliminate cervical cancer: vaccinate 90% of girls by age 15, screen 70% of women by 35 and 45, and treat 90% of cases. But meeting these goals demands more than science — it needs political will, public funding, and sustained awareness.
(Credit-Canva)
Lower back pain is a constant issue for many people. While it may seem like a minor inconvenience to some, it can severely impact their quality of life. For people who are suffering from ongoing back pain, finding relief can be incredibly challenging.
While there are medications available, there are side-effects one must consider. However, new research suggests that two types of therapy might offer a promising solution, especially for those who have been relying on opioid medications.
A study published April 7 in JAMA Network Open found that mindfulness-based therapy (MBT) and cognitive behavioral therapy (CBT) significantly improved the quality of life for people managing chronic low back pain with opioids. Participants reported less pain and were able to reduce their opioid dosages in the months following the start of these therapies.
Researchers noted that the participants had lived with moderate to severe back pain for a long time, most for over five years, and had tried many other treatments without success. The improvements seen were therefore even more significant.
Chronic low back pain affects a large number of people; data suggests that as many as 28% of Americans experience it. Despite its prevalence, effective treatments are often hard to come by. One study in March found that only 10% of non-surgical treatments for lower back pain actually work. This led researchers to explore whether CBT and MBT could offer a better approach.
Cognitive Behavioral Therapy (CBT) helps patients identify negative thoughts and behaviors, then uses problem-solving and self-reflection to change those patterns.
Mindfulness-Based Therapy (MBT) teaches people to observe their bodily sensations, feelings, and thoughts without reacting to them, often through meditation to focus on the present moment.
The study involved 770 adults who were using opioids for their chronic low back pain. On average, participants were about 58 years old and experienced moderate-to-severe pain, limitations in their daily activities, and a reduced quality of life.
Half of the participants received CBT, and the other half received MBT. They attended weekly two-hour group sessions for eight weeks. After this, they were encouraged to practice what they learned for 30 minutes daily, six days a week, for the remainder of the 12-month study. Although about 30% of participants dropped out by the six-month mark, those who continued reported:
These benefits lasted throughout the year, with over 65% of participants still reporting progress at the 12-month mark. Dr. Zgierska highlighted that chronic back pain usually doesn't get better on its own, often worsening over time, which makes these lasting improvements particularly striking. Since both therapies showed similar positive results, people can confidently choose the approach that best suits them, whether it's the structured nature of CBT or the mindfulness focus of MBT. Both in-person and online formats were found to be effective.
While this JAMA Network Open study didn't include a control group or have much racial and ethnic diversity among its participants, its findings align with other research suggesting that behavioral therapies can help adults using opioids for chronic pain.
It's important to note that this area still needs more research. Only 17 studies have looked at MBT for chronic low back pain, and only three have directly compared it to CBT. However, previous studies have shown that both MBT and CBT are generally effective for pain relief, even if they haven't always included people on opioids for chronic back pain. The fact that this new research shows they help in more severe cases (with opioid use) further strengthens these findings.
© 2024 Bennett, Coleman & Company Limited